Notably, CIN type is genetically characterized by the mutation of TP53 (71%), which indicates the critical role of H. pylori CagA/PAR1b-mediated BRCAness in the development of CIN-type gastric cancer. The gene discussed is MARK2; the disease is gastric cancer.